Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10858359 Heterocyclic ring derivatives useful as SHP2 inhibitors

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
June 7, 2017
Date of Patent
December 8, 2020
Patent Application Number
16307827
Patent Citations
‌
US Patent 10287266 Compounds and compositions for inhibiting the activity of SHP2
‌
US Patent 10301278 1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2
‌
US Patent 10377742 AMPK-activating heterocyclic compounds and methods for using the same
‌
US Patent 10329270 Heteroaryl compounds as BTK inhibitors and uses thereof
‌
US Patent 10463662 Non-platinum-based anti-cancer compounds for use in targeted chemotherapy
‌
US Patent 10077276 N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
‌
US Patent 10253046 TYK2 inhibitors and uses thereof
Patent Citations Received
‌
US Patent 10988466 Heterocyclic derivatives useful as SHP2 inhibitors
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10858359
Patent Primary Examiner
‌
John S Kenyon

Find more entities like US Patent 10858359 Heterocyclic ring derivatives useful as SHP2 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo